Optimal use of radium-223 in patients with metastatic castration-resistant prostate cancer.
Optimal use of radium-223 in patients with metastatic castration-resistant prostate cancer.
Clin Adv Hematol Oncol. 2017 Sep;15(9):690-694
Authors: George DJ
PMID: 28949940 [PubMed - in process]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research